Medtronic Neurovascular, a pioneer and global leader in stroke care, is proud to announce the appointment of Dr. Adam S. Arthur as Chief Medical Officer, effective September 30, 2025. Dr. Arthur brings more than 20 years of experience as a practicing neurosurgeon, having previously served as Chair of Neurosurgery at the University of Tennessee Health Science Center. His leadership in clinical trials and commitment to innovation have driven improved outcomes for stroke patients and advanced the field of neurovascular care.
READ MORE




